The announcement that a vaccine might be available before the end of the month that works and is safe changed everything - and nothing. The optimists in markets decided that the news would be confirmed and get better. The vaccine they think will complete its trials, it will pass its safety test and the Regulators will wave it through into use many months short of the normal trial periods. It would they hope be followed by one or two more vaccines that could similarly be fast tracked, as if one company can find a way to stop the disease, so surely must others be able to do the same.…
The journal CrystEngComm has published a special issue to mark the Cambridge Structural Database (CSD) reaching 1 million structures, with 33 papers that highlight the breadth of applications made possible with this data.
The Royal Society of Chemistry journal CrystEngComm has published new research on all aspects in the design and understanding of solid-state and crystalline materials since 1999. They publish work covering a wide range of chemistries, but all involve the use of a design or optimisation strategy to develop a deeper understanding of the structures.
"The breadth of…
Under RIDDOR (a health and safety regulation) employers now have a duty to report cases where employees have contracted COVID as a result of direct exposure due to work activities. Three specific circumstances have been identified: 1) “An accident or incident at work has, or could have, led to the release or escape of coronavirus”, 2) “A worker has been diagnosed with COVID-19 attributed to an occupational exposure to coronavirus.” 3) A worker dies as a result of occupational exposure to coronavirus. This must be reported as a work-related death due to exposure to a biological agent."
As…
Prof Dell’ Accio and Dr Suzanne Eldridge from Queen Mary University of London have discovered a new therapeutic treatment for osteochondral defects shown to regenerate the cartilage and provide rapid, long-term pain relief.
These findings have been published in Science of Translational Medicine https://stm.sciencemag.org/content/12/559/eaax9086 and featured widely in the media https://sciencetm.altmetric.com/details/89347825#score.
A patent application has also been filed for this opportunity. QMI is currently looking for partners to develop this technology further and progress into…
New report shows 10% of UK’s top female BioBusiness talent is based at Stevenage Bioscience Catalyst
A report released today by BioBeat showcasing the 30 top female leaders in the UK bioscience sector has named three people from organisations based at Stevenage Bioscience Catalyst (SBC), totalling 10% of the list.
The three mentioned leaders based at SBC are Shree Patel from Achilles Therapeutics, Nicole Mathon from LifeArc and Bakul Gupta from ImmTune Therapies.
This is the seventh annual Movers and Shakers report released by BioBeat, and this year highlighted individuals pioneering scientists, financial experts, collaborators, innovators focused on impact on patients’ lives, and…
Leading pharmaceutical and biotech product development consultancy Boyds has added to its regulatory team with the appointment of experienced toxicologist, Dr Geoffrey Rose in response to the continued increase in demand for its dedicated regulatory services.
With more than 20 years’ regulatory experience across the full clinical product lifecycle, regulatory toxicologist Geoffrey joins Boyds as Director of Regulatory Affairs.
At Boyds, Geoffrey will provide strategic regulatory advice and support to Boyds’ clients across a range of therapeutic areas and all development stages of small and…
New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations
Cambridge, United Kingdom – 9 November 2020 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the completion of its Series C funding round, raising US$50m/£39m.
The round was co-led by Tencent and Legal & General and included other new investors Xeraya, Puhua Capital and IDO Investments. Existing investors Parkwalk, Cambridge Innovation…
Biocair, a global logistics company dedicated to the life sciences, has partnered with Roylance Pharma to deliver fully integrated transportation and storage services for temperature-controlled pharmaceutical and biological materials.
Roylance Pharma brings more than 50 years’ experience in controlled storage services, including outsourced licensed storage, validation and maintenance, while Biocair provides its global logistics and regulatory compliance expertise. This partnership gives Biocair’s customers access to secure, temperature-controlled and licensed storage facilities at strategic…
Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability
PhoreMost’s SITESEEKER® platform will identify active peptides to be deployed within Oxford Biomedica’s LentiVector ® delivery system
Cambridge and Oxford, UK, 09 November 2020: PhoreMost Limited, the UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, and Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”), a leading gene and cell therapy group, today announced that they have entered into a discovery collaboration to develop next-generation…
- Integrated lead optimisation to advance APEIRON’s Cbl-b inhibitor development programme APN431
- Inhibitors discovered at Domainex via virtual and fragment screening
Vienna, Austria and Saffron Waldon, UK, 9th November 2020 / Sciad Newswire / APEIRON Biologics AG, a privately-held biotech company developing breakthrough therapies to treat cancer and respiratory conditions, has selected Domainex Ltd to provide integrated lead optimisation services in order to advance the development of inhibitors for the E3 ubiquitin ligase Cbl-b through small molecule drug discovery.
Under the terms of the…